Tenaya Therapeutics, Inc. — All Filings
318 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001193125-26-102252 | Mar 11, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-102170 | Mar 11, 2026 | — |
| 8-K | 8-K | 0001193125-26-092654 | Mar 5, 2026 | Mar 4, 2026 |
| SCHEDULE 13D/A | — | 0001193125-26-076892 | Feb 26, 2026 | — |
| 4 | 4 | 0001193125-26-076814 | Feb 26, 2026 | Feb 24, 2026 |
| 144 | — | 0001178937-26-000013 | Feb 25, 2026 | — |
| 144 | — | 0001178937-26-000012 | Feb 25, 2026 | — |
| 4 | 4 | 0001193125-26-067007 | Feb 24, 2026 | Feb 20, 2026 |
| 144 | — | 0001178937-26-000009 | Feb 20, 2026 | — |
| 144 | — | 0001178937-26-000008 | Feb 20, 2026 | — |
| 4 | 4 | 0001193125-26-055445 | Feb 17, 2026 | — |
| 4 | 4 | 0001193125-26-055442 | Feb 17, 2026 | — |
| 4 | 4 | 0001193125-26-055439 | Feb 17, 2026 | — |
| 144 | — | 0001193125-26-055437 | Feb 17, 2026 | — |
| 144 | — | 0001193125-26-055434 | Feb 17, 2026 | — |
| SCHEDULE 13D/A | — | 0001193125-26-049218 | Feb 12, 2026 | — |
| 4 | 4 | 0001193125-26-049028 | Feb 12, 2026 | Feb 10, 2026 |
| 144 | — | 0001178937-26-000007 | Feb 11, 2026 | — |
| 144 | — | 0001178937-26-000006 | Feb 11, 2026 | — |
| 144 | — | 0001178937-26-000005 | Feb 10, 2026 | — |
| 144 | — | 0001178937-26-000004 | Feb 10, 2026 | — |
| 4 | 4 | 0001193125-26-039768 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-039763 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-039760 | Feb 5, 2026 | Feb 3, 2026 |
| S-8 | S-8 | 0001193125-26-035501 | Feb 3, 2026 | — |
| 8-K | 8-K | 0001193125-26-032017 | Jan 30, 2026 | Jan 26, 2026 |
| 8-K | 8-K | 0001193125-26-001065 | Jan 2, 2026 | Dec 31, 2025 |
| SCHEDULE 13D/A | — | 0001193125-25-322770 | Dec 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-317642 | Dec 12, 2025 | Dec 11, 2025 |
| 424B5 | 424B5 | 0001193125-25-317609 | Dec 12, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-316104 | Dec 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-315951 | Dec 11, 2025 | — |
| 4 | 4 | 0001193125-25-284999 | Nov 17, 2025 | — |
| 4 | 4 | 0001193125-25-284997 | Nov 17, 2025 | — |
| 4 | 4 | 0001193125-25-284996 | Nov 17, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-273239 | Nov 10, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-273230 | Nov 10, 2025 | — |
| 8-K | 8-K | 0001193125-25-272423 | Nov 7, 2025 | — |
| UPLOAD | — | 0000000000-25-009790 | Sep 10, 2025 | — |
| CORRESP | — | 0001858848-25-000007 | Sep 4, 2025 | — |
| UPLOAD | — | 0000000000-25-009101 | Aug 26, 2025 | — |
| 4 | 4 | 0000950170-25-109915 | Aug 18, 2025 | — |
| 4 | 4 | 0001868494-25-000006 | Aug 18, 2025 | — |
| 4 | 4 | 0001667937-25-000006 | Aug 18, 2025 | — |
| 144 | — | 0001868494-25-000005 | Aug 18, 2025 | — |
| 144 | — | 0001667937-25-000005 | Aug 18, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003594 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-104182 | Aug 6, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-104164 | Aug 6, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003291 | Jul 31, 2025 | — |